Join our community of smart investors

Haleon hails resilient power brands

The consumer health group has outperformed peers in terms of volume and sales growth – but there are reasons to be wary
August 3, 2023
  • Margins fall as cost inflation persists
  • Uncertainty around Pfizer and GSK exits

Management at Haleon (HLN), formerly the consumer health arm of GSK (GSK), is the first to admit that the group’s “power brands” are the major drivers of its growth. This is a cohort that includes Sensodyne toothpaste and Panadol painkillers, among other recognisable brands.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in